Apolipoprotein-E influences aspects of intellectual ability in type 1 diabetes

Diabetes

Volumn 52, Issue 1, 2003, Pages 145-148

  Ferguson, Stewart C ^a   Deary, Ian J ^b   Evans, Julie C ^c   Ellard, Sian ^c   Hattersley, Andrew T ^c   Frier, Brian M ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CROSSOVER PROCEDURE; FEMALE; FRONTAL LOBE; GENOTYPE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTELLIGENCE; INTELLIGENCE TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MULTIVARIATE ANALYSIS OF COVARIANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL MODEL; VERBAL COMMUNICATION;

ADULT; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; HYPOGLYCEMIA; INTELLIGENCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0037221489     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.1.145     Document Type: Article

References (25)

1. Tattersall RB: Frequency, causes and treatment of hypoglycaemia. In Hypoglycaemia in Clinical Diabetes. Frier BM, Fisher BM, Eds. Chichester, John Wiley & Sons Ltd., 1999, p. 55-88
2. Perros P, Deary IJ: Long term effect of hypoglycaemia on cognitive function and the brain in diabetes. In Hypoglycaemia in Clinical Diabetes. Frier BM, Fisher BM, Eds. Chichester, John Wiley & Sons Ltd., 1999, p. 187-210
3. Diabetes Control and Complications Trial Research Group: Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379-388, 1996
4. Reichard P, Pihl M, Rosenqvist U, Sule J: Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow tip. Diabetologia 39:1483-1488, 1996
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923, 1993
6. Maclullich AMJ, Seckl JR, Starr JM, Deary IJ: The biology of intelligence: From association to mechanism. Intelligence 26:63-73, 1998
7. Flory JD, Manuck SB, Ferrell RE, Ryan CM, Muldoon MF: Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet 96:707-711, 2000
8. Smith JD: Apolipoprotein E4: An allele associated with many diseases. Ann Med 32:118-127, 2000
9. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM: Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42:341-344, 1993
10. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJK, Wardlaw J, Dreary IJ, Frier BM: Cognitive ability and brain structure in type 1 diabetes: Relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149-156, 2003
11. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
12. Wechsler D: Manual for the Wechsler Adult Intelligence Scale-Revised. New York, Psychological Corporation, 1981
13. Nelson HE, Willison JR: National Adult Reading Test (NART) Test Manual. 2nd Ed. Windsor, NFER-Nelson, 1991
14. McCrimmon RJ, Deary IJ, Huntly BJH, MacLeod KJM, Frier BM: Visual information processing during controlled hypoglycaemia in humans. Brain 119:1277-1287, 1996
15. Jensen AR: Individual differences in the Hick paradigm. In Speed of Infomation Processing and Intelligence. Vernon PA, Ed. Norwood, NJ, Ablex, 1987, p. 101-175
16. Borkowski JG, Benton AL: Word fluency and brain damage. Neuropsychologia 5:135-140, 1967
17. Deary IJ, Langan SJ, Hepburn DA, Frier BM: Which abilities does the PASAT test? Pers Indiv Diff 12:983-987, 1991
18. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271-286, 1997
19. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159, 1991
20. Mortensen EL, Hogh P: A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57:89-95, 2001
21. Turic D, Fisher PJ, Plomin R, Owen MJ: No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neurosci Lett 299:97-100, 2001
22. Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ: Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294:179-181, 2000
23. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D: Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 27:2230-2235, 1996
24. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L: The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40-46, 1999
25. Shuvaev W, Fujii J, Kawasaki Y, Itoh H, Hamaoka R, Barbier A, Ziegler O, Siest G, Taniguchi N: Glycation of apolipoprotein E impairs its binding to heparin: Identification of the major glycation site. Biochim Biophys Acta 1454:296-308, 1999